Symptom → Plant Sources
Greater Celandine (Chelidonium majus) as a tool for helping with Inflammation (general)
inferred from anti-inflammatory action
← Back to Symptom-to-Plant Lookup
Full Greater Celandine monograph →All plants for inflammation (general) →
Chelidonium majus L. (family Papaveraceae), or greater celandine, is an important plant in western phytotherapy and in traditional Chinese medicine. Crude extracts of C. majus as well as purified compounds derived from it exhibit a broad spectrum of biological activities (antiinflammatory, antimicrobial, antitumoral, analgesic, hepatoprotective) that support some of the traditional uses of C. majus. However, herbal medicine also claims that this plant has several important properties which have not yet been scientifically studied: C. majus is supposed to have diuretic, antitussive and eye-regenerative effects. On the other hand, C. majus also has scientifically proven effects, e.g. anti-osteoporotic activity and radioprotection, which are not mentioned in traditional sources. Moreover, recent controversy about the hepatoprotective versus hepatotoxic effects of Chelidonium majus has renewed the interest of the medical community in this plant. This review is intended to integrate traditional ethno-medical knowledge and modern scientific findings about C. majus in order to promote understanding of its therapeutic actions as well as its toxic potential.
1 source supporting Greater Celandine for Inflammation (general). Includes scientific publications, books, monographs and traditional-use references.
Mechanistic basis
This use is associated with the plant's anti-inflammatory action. Further evidence for that pharmacology:
Chelidonium majus has rich medicinal value, traditionally used to alleviate coughs, asthma, spasms and pain. It is abundant in alkaloids (94 isolated, including benzophenanthridine, protoberberine, aporphine and protopine types) which have anti-microbial, anti-inflammatory, anti-viral and anti-tumor effects. The review covers the phytochemistry, pharmacology and toxicology of C. majus alkaloids, noting the toxicity that limits internal use.
A protoberberine-rich fraction of Chelidonium majus (greater celandine) promoted endometriosis regression by reducing lesion growth and inflammation, supporting the anti-inflammatory use of greater celandine.